FDA Form 3454

Document technical information

Format pdf
Size 48.6 kB
First found May 22, 2018

Document content analysis

Category Also themed
Language
English
Type
not defined
Concepts
no text concepts found

Persons

Organizations

Places

Transcript

Print
Save As...
E-mail Form
Reset Form
Form Approved: OMB No. 0910-0396
Expiration Date: April 30, 2009
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
CERTIFICATION: FINANCIAL INTERESTS AND
ARRANGEMENTS OF CLINICAL INVESTIGATORS
TO BE COMPLETED BY APPLICANT
With respect to all covered clinical studies (or specific clinical studies listed below (if appropriate)) submitted in
support of this application, I certify to one of the statements below as appropriate. I understand that this
certification is made in compliance with 21 CFR part 54 and that for the purposes of this statement, a clinical
investigator includes the spouse and each dependent child of the investigator as defined in 21 CFR 54.2(d).
Please mark the applicable checkbox.
Clinical Investigators
(1) As the sponsor of the submitted studies, I certify that I have not entered into any financial arrangement
with the listed clinical investigators (enter names of clinical investigators below or attach list of names
to this form) whereby the value of compensation to the investigator could be affected by the outcome
of the study as defined in 21 CFR 54.2(a). I also certify that each listed clinical investigator required to
disclose to the sponsor whether the investigator had a proprietary interest in this product or a
significant equity in the sponsor as defined in 21 CFR 54.2(b) did not disclose any such interests. I
further certify that no listed investigator was the recipient of significant payments of other sorts as
defined in 21 CFR 54.2(f).
(2) As the applicant who is submitting a study or studies sponsored by a firm or party other than the
applicant, I certify that based on information obtained from the sponsor or from participating clinical
investigators, the listed clinical investigators (attach list of names to this form) did not participate in any
financial arrangement with the sponsor of a covered study whereby the value of compensation to the
investigator for conducting the study could be affected by the outcome of the study (as defined in 21
CFR 54.2(a)); had no proprietary interest in this product or significant equity interest in the sponsor of
the covered study (as defined in 21 CFR 54.2(b)); and was not the recipient of significant payments of
other sorts (as defined in 21 CFR 54.2(f)).
(3) As the applicant who is submitting a study or studies sponsored by a firm or party other than the
applicant, I certify that I have acted with due diligence to obtain from the listed clinical investigators
(attach list of names) or from the sponsor the information required under 54.4 and it was not possible
to do so. The reason why this information could not be obtained is attached.
NAME
TITLE
FIRM /ORGANIZATION
SIGNATURE
DATE
Paperwork Reduction Act Statement
An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number. Public reporting burden for this
collection of information is estimated to average 1 hour per response, including time for reviewing
instructions, searching existing data sources, gathering and maintaining the necessary data, and
completing and reviewing the collection of information. Send comments regarding this burden estimate
or any other aspect of this collection of information to the address to the right:
FORM FDA 3454 (4/06)
Department of Health and Human Services
Food and Drug Administration
5600 Fishers Lane, Room 14C-03
Rockville, MD 20857
PSC Graphics: (301) 443-1090
EF

Similar documents

×

Report this document